Table 2.
Age group | Gender | Latest estimate (95% CrIa) | Range of median estimates | Crude case fatality rate (95% CIb) |
---|---|---|---|---|
Overall | 3.72% (3.67–3.78%) | 3.72–9.94% | 3.54% (3.49–3.60%) | |
Male | 4.16% (4.09–4.24%) | 4.16–10.20% | 3.97% (3.90–4.05%) | |
Female | 3.26% (3.19–3.34%) | 3.26–10.19% | 3.09% (3.02–3.17%) | |
0–9 | Male | 0.23% (0.13–0.34%) | 0.17–0.31% | 0.21% (0.12–0.32%) |
Female | 0.23% (0.14–0.35%) | 0.23–0.83% | 0.21% (0.13–0.33%) | |
10–19 | Male | 0.13% (0.07–0.22%) | 0.11–0.53% | 0.12% (0.07–0.20%) |
Female | 0.06% (0.03–0.12%) | 0.04–0.28% | 0.06% (0.03–0.11%) | |
20–29 | Male | 0.14% (0.11–0.18%) | 0.14–0.38% | 0.14% (0.11–0.17%) |
Female | 0.08% (0.06–0.11%) | 0.08–0.92% | 0.08% (0.06–0.11%) | |
30–39 | Male | 0.33% (0.28–0.39%) | 0.33–2.18% | 0.31% (0.27–0.37%) |
Female | 0.20% (0.16–0.24%) | 0.10–0.36% | 0.19% (0.15–0.23%) | |
40–49 | Male | 0.96% (0.87–1.07%) | 0.86–4.42% | 0.92% (0.84–1.02%) |
Female | 0.59% (0.51–0.67%) | 0.32–1.24% | 0.56% (0.49–0.64%) | |
50–59 | Male | 3.12% (2.94–3.31%) | 2.76–7.36% | 2.99% (2.81–3.17%) |
Female | 1.66% (1.52–1.80%) | 1.63–3.02% | 1.58% (1.45–1.72%) | |
60–69 | Male | 10.16% (9.76–10.60%) | 10.16–33.29% | 9.69% (9.31–10.10%) |
Female | 6.44% (6.10–6.81%) | 5.98–27.32% | 6.11% (5.78–6.45%) | |
70–79 | Male | 28.35% (27.49–29.35%) | 27.27–72.74% | 26.97% (26.15–27.92%) |
Female | 18.18% (17.40–18.93%) | 18.16–69.30% | 17.25% (16.51–17.96%) | |
80– | Male | 56.82% (55.25–58.34%) | 56.82–99.26% | 53.62% (52.14–55.05%) |
Female | 41.10% (40.02–42.26%) | 40.80–97.86% | 39.13% (38.10–40.23%) |
aCrI credibility intervals
bCI confidence interval
cCumulative cases over cumulative deaths